All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

GlaxoSmithkline Pharmaceuticals Limited revenue reports

GlaxoSmithkline Pharmaceuticals Limited financial reports, GlaxoSmithkline Pharmaceuticals Limited annual revenue in 2024. When does GlaxoSmithkline Pharmaceuticals Limited report revenue?
Add to widgets
Added to widgets

GlaxoSmithkline Pharmaceuticals Limited total revenue, net income and dynamics of changes in Indian rupee today

GlaxoSmithkline Pharmaceuticals Limited current income and income for the latest reporting periods. Net income GlaxoSmithkline Pharmaceuticals Limited - 1 108 300 000 Rs. Information about net income is used from open sources. Net income, revenue and dynamics - the main financial indicators of GlaxoSmithkline Pharmaceuticals Limited. Graph of finance company GlaxoSmithkline Pharmaceuticals Limited. The financial graph of GlaxoSmithkline Pharmaceuticals Limited shows the values and changes of such indicators: total assets, net income, net revenue. The financial report chart shows the values from 31/12/2018 to 30/06/2020.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2020 6 485 900 000 Rs -17.688 % ↓ 1 108 300 000 Rs -2.387 % ↓
31/03/2020 7 758 007 000 Rs - 1 380 746 000 Rs -
31/12/2019 7 785 900 000 Rs -5.665 % ↓ -6 611 600 000 Rs -681.649 % ↓
30/09/2019 8 820 200 000 Rs - 5 027 500 000 Rs -
30/06/2019 7 879 700 000 Rs - 1 135 400 000 Rs -
31/12/2018 8 253 500 000 Rs - 1 136 700 000 Rs -
Show:
to

GlaxoSmithkline Pharmaceuticals Limited financial report charts

The dates of the latest financial statements of GlaxoSmithkline Pharmaceuticals Limited: 31/12/2018, 31/03/2020, 30/06/2020. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of GlaxoSmithkline Pharmaceuticals Limited is 30/06/2020. Gross profit GlaxoSmithkline Pharmaceuticals Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit GlaxoSmithkline Pharmaceuticals Limited is 3 912 600 000 Rs

GlaxoSmithkline Pharmaceuticals Limited quarterly report dates

Cost of revenue GlaxoSmithkline Pharmaceuticals Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue GlaxoSmithkline Pharmaceuticals Limited is 2 573 300 000 Rs Total revenue GlaxoSmithkline Pharmaceuticals Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue GlaxoSmithkline Pharmaceuticals Limited is 6 485 900 000 Rs Operating income GlaxoSmithkline Pharmaceuticals Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income GlaxoSmithkline Pharmaceuticals Limited is 923 000 000 Rs

Net income GlaxoSmithkline Pharmaceuticals Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income GlaxoSmithkline Pharmaceuticals Limited is 1 108 300 000 Rs

30/06/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
3 912 600 000 Rs 4 792 077 000 Rs 4 508 400 000 Rs 5 121 500 000 Rs 4 571 800 000 Rs 4 427 700 000 Rs
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 573 300 000 Rs 2 965 930 000 Rs 3 277 500 000 Rs 3 698 700 000 Rs 3 307 900 000 Rs 3 825 800 000 Rs
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
6 485 900 000 Rs 7 758 007 000 Rs 7 785 900 000 Rs 8 820 200 000 Rs 7 879 700 000 Rs 8 253 500 000 Rs
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - 7 785 900 000 Rs 8 820 200 000 Rs 7 879 700 000 Rs 8 253 500 000 Rs
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
923 000 000 Rs 1 638 123 000 Rs 1 060 600 000 Rs 1 713 100 000 Rs 1 462 300 000 Rs 1 251 100 000 Rs
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 108 300 000 Rs 1 380 746 000 Rs -6 611 600 000 Rs 5 027 500 000 Rs 1 135 400 000 Rs 1 136 700 000 Rs
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 562 900 000 Rs 6 119 884 000 Rs 6 725 300 000 Rs 7 107 100 000 Rs 6 417 400 000 Rs 7 002 400 000 Rs
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
- 17 748 814 000 Rs - 16 130 400 000 Rs - -
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
- 31 355 410 000 Rs - 35 195 400 000 Rs - -
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
- 1 048 115 000 Rs - 9 203 300 000 Rs - -
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - 8 151 800 000 Rs - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - 11 738 900 000 Rs - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - 33.35 % - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
18 206 049 000 Rs 18 206 049 000 Rs 23 456 500 000 Rs 23 456 500 000 Rs 21 398 292 000 Rs -
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - - -

Last revenue report of GlaxoSmithkline Pharmaceuticals Limited was 30/06/2020. According to last financial report total revenue in GlaxoSmithkline Pharmaceuticals Limited was 6 485 900 000 Indian rupee and changed by -17.688% since last year. Net income in GlaxoSmithkline Pharmaceuticals Limited was 1 108 300 000 Rs in last quartal, net income changes to -2.387%.

GlaxoSmithkline Pharmaceuticals Limited stocks data

GlaxoSmithkline Pharmaceuticals Limited financials